Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
Beyond PTEN: Alternate Genes Linked To Breast, Thyroid And Kidney Cancer Predisposition
http://www.medicalnewstoday.com/articles/117660.php
A new discovery may lead to more effective screening and treatment for patients with a difficult to recognize syndrome characterized by tumor-like growths and a high risk of developing specific cancers.
First Step Towards Switching Off Breast Cancer And Leukaemia
http://www.medicalnewstoday.com/articles/117642.php
Australian scientists have identified a way to 'switch off' a molecule, a key player in the molecular processes that trigger breast cancer and certain forms of leukaemia. The molecule, known as Gab2, operates downstream of a major breast cancer oncogene, HER2, the target of the drug Herceptin.
----------------------------------------------
** CANCER / ONCOLOGY News **
Pre-Cancerous Condition Linked To Chronic Acid Reflux Faces Several Hurdles
http://www.medicalnewstoday.com/articles/117668.php
A pre-cancerous condition linked to chronic acid reflux often gets overlooked. Can the medical community do a better job intervening? Researchers from the Hutchinson-MRC Research Centre in Cambridge think so.
Beyond PTEN: Alternate Genes Linked To Breast, Thyroid And Kidney Cancer Predisposition
http://www.medicalnewstoday.com/articles/117660.php
A new discovery may lead to more effective screening and treatment for patients with a difficult to recognize syndrome characterized by tumor-like growths and a high risk of developing specific cancers.
Novel Assay Finds That Widely Prescribed Anti-Parasite Drug Targets Cancer-Causing Protein
http://www.medicalnewstoday.com/articles/117647.php
Researchers at the NYU Cancer Institute and the Ronald O. Perelman Department of Dermatology have identified mebendazole, a drug used globally to treat parasitic infections, as a novel investigational agent for the treatment of chemotherapy-resistant malignant melanoma.
Structural Biology Spin-Out Tackles Major Diseases
http://www.medicalnewstoday.com/articles/117644.php
A spin out company from basic structural biology, Asterion Ltd., has led to new technology that provides a way of creating therapeutic proteins to tackle major diseases such as cancer, diabetes and infertility.
AnaSpec Introduces New SensoLyte™ 570 Generic MMP Assay Kit With Industry's Highest Wavelength
http://www.medicalnewstoday.com/articles/117643.php
Matrix metalloproteinases (MMPs) belong to a family of secreted or membrane-associated proteins capable of digesting extracellular matrix components. The importance of MMPs in tumor development and invasion as well as other diseases is well known.
ARIAD Announces Start Of Phase 2 Clinical Study Of Oral Deforolimus In Patients With Advanced Endometrial Cancer
http://www.medicalnewstoday.com/articles/117639.php
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) announced the initiation of a randomized, multi-center, Phase 2 clinical trial to evaluate the safety and efficacy of oral deforolimus, its investigational mTOR inhibitor, in patients with advanced endometrial cancer.
Researchers Demonstrate Activity Of Mebendazole In Metastatic Melanoma
http://www.medicalnewstoday.com/articles/117626.php
Researchers at the NYU Cancer Institute and the Ronald O. Perelman Department of Dermatology have identified mebendazole, a drug used globally to treat parasitic infections, as a novel investigational agent for the treatment of chemotherapy-resistant malignant melanoma.
How Tumor Suppress Or Inhibits Cell Growth
http://www.medicalnewstoday.com/articles/117623.php
Genes that inhibit the spontaneous development of cancer are called tumor suppressor genes. One of the major tumor suppressors is p53, a protein that acts in the cell nucleus to control the expression of other genes whose products can inhibit cell proliferation (increase in cell number) and cell growth (increase in cell size).
Early Warning Of Leukaemia Or False Alarm?
http://www.medicalnewstoday.com/articles/117592.php
Researchers have for the first time shown that many people have cells in their blood which appear identical to leukaemia and yet the risk of developing the disease for most is virtually zero.
Researchers Find Cancer-Inhibiting Compound Under The Sea, University Of Florida
http://www.medicalnewstoday.com/articles/117586.php
University of Florida College of Pharmacy researchers have discovered a marine compound off the coast of Key Largo that inhibits cancer cell growth in laboratory tests, a finding they hope will fuel the development of new drugs to better battle the disease.
Researchers Unveil Vital Key To Cancer
http://www.medicalnewstoday.com/articles/117583.php
University of Manchester scientists have uncovered the 3D structure of Mps1 - a protein that regulates the number of chromosomes during cell division and thus has an essential role in the prevention of cancer - which will lead to the design of safer and more effective therapies.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
No news for this category today.
----------------------------------------------
** COLORECTAL CANCER News **
No news for this category today.
----------------------------------------------
** LUNG CANCER News **
No news for this category today.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
Why Gene Therapy Caused Leukemia In Some "Boy In The Bubble Syndrome" Patients
http://www.medicalnewstoday.com/articles/117654.php
Severe combined immunodeficiency (SCID), sometimes called 'Boy in the bubble syndrome', is a genetic disorder in which the patient lacks most types of immune cell. Almost 10 years ago, two independent groups (one in London, United Kingdom, and one in Paris, France) used gene therapy to treat a few infants with the most common form of SCID, SCID-X1, which is caused by mutations in the IL2RG gene.
First Step Towards Switching Off Breast Cancer And Leukaemia
http://www.medicalnewstoday.com/articles/117642.php
Australian scientists have identified a way to 'switch off' a molecule, a key player in the molecular processes that trigger breast cancer and certain forms of leukaemia. The molecule, known as Gab2, operates downstream of a major breast cancer oncogene, HER2, the target of the drug Herceptin.
InNexus Biotechnology Announces Launch Of Large Scale Primate Study Of DXL625
http://www.medicalnewstoday.com/articles/117621.php
InNexus Biotechnology Inc., (TSX: IXS.V; OTC Bulletin Board: IXSBF) (<a href="http://www.ixsbio.com" target="_blank" rel="nofollow">http://www.ixsbio.com</a>), a drug development company commercializing the next generation of monoclonal antibodies based on its Dynamic Cross Linking (DXL(TM)) technology, announced that it has launched a large scale primate study of DXL625 (CD20), the company's lead program.
Early Warning Of Leukaemia Or False Alarm?
http://www.medicalnewstoday.com/articles/117592.php
Researchers have for the first time shown that many people have cells in their blood which appear identical to leukaemia and yet the risk of developing the disease for most is virtually zero.
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
Updated Licence For Goserelin (Zoladex 3.6 Mg & Zoladex La 10.8mg) Reflects Survival Benefits In All Stages Of Prostate Cancer
http://www.medicalnewstoday.com/articles/117585.php
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved an updated licence to goserelin 3.6mg and goserelin LA 10.8mg [i] to reflect survival benefits in all three stages of prostate cancer (localised, locally advanced and advanced also called metastatic).
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment